Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Headington, Oxford, United Kingdom Clinical Trials

A listing of Headington, Oxford, United Kingdom clinical trials actively recruiting patients volunteers.

RESULTS

Found (5) clinical trials

Study to Evaluate Tezepelumab on Airway Inflammation in Adults With Uncontrolled Asthma (CASCADE)

This is a multicentre, randomized, double-blind, placebo-controlled, parallel group study to evaluate the effect of tezepelumab on airway inflammation in adults with inadequately controlled moderate-to-severe asthma, taking inhaled corticosteroids and at least one additional asthma controller. Approximately 110 subjects will be randomized globally. Subjects will receive tezepelumab, or placebo, administered ...

Phase

0.91 miles

Learn More »

Hypertension Management in Young Adults Personalised by Echocardiography and Clinical Outcome.

HyperEcho is a multi-centre longitudinal observational study, to investigate whether baseline transthoracic echocardiography along with routine data collected in the hypertension clinic can guide clinicians to better manage, and improve risk stratification for cardiovascular disease in young adults with hypertension. Participants are characterised as hypertensive patients aged between 18 to ...

Phase N/A

0.91 miles

Learn More »

The purpose of this study is to determine the safety and tolerability and assess preliminary efficacy of INCAGN01949 in subjects with advanced or metastatic solid tumors.  

Phase

1.09 miles

Learn More »

IDEAL: Artificial Intelligence and Big Data for Early Lung Cancer Diagnosis Study

As the commonest cancer with 1.8 million cases diagnosed each year worldwide, early diagnosis of lung cancer is important to reduce mortality. The early diagnosis of lung cancer is contingent on both the detection of a small lung nodule and determining whether it is malignant. Whilst computed tomography (CT) has ...

Phase N/A

1.09 miles

Learn More »

Study of RP1 Monotherapy and RP1 in Combination With Nivolumab

RP1 is a genetically modified herpes simplex type 1 virus that is designed to directly destroy tumors and to generate an anti-tumor immune response. This is a Phase 1/2, open label, multicenter, dose escalation and expansion, first-in-human (FIH) clinical study to evaluate the safety and tolerability, biodistribution, shedding, and preliminary ...

Phase

2.63 miles

Learn More »